[Clinical guidelines on anti-D prophylaxis: hasty critics?].
作者信息
Carbonne B, Marpeau L, Brossard Y
出版信息
J Gynecol Obstet Biol Reprod (Paris). 2007 Oct;36(6):526-8. doi: 10.1016/j.jgyn.2007.09.002.
PMID:17893030
Abstract
摘要
相似文献
1
[Clinical guidelines on anti-D prophylaxis: hasty critics?].
J Gynecol Obstet Biol Reprod (Paris). 2007 Oct;36(6):526-8. doi: 10.1016/j.jgyn.2007.09.002.
2
[Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
J Gynecol Obstet Biol Reprod (Paris). 2007 Oct;36(6):523-5. doi: 10.1016/j.jgyn.2007.06.010. Epub 2007 Jul 24.
3
[Should the RhD prophylaxis be adjusted?].
Ugeskr Laeger. 2004 Aug 30;166(36):3072.
4
[RhD immunoprophylaxis should be adjusted].
Ugeskr Laeger. 2004 Aug 30;166(36):3113.
5
[Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
Ugeskr Laeger. 2004 Aug 30;166(36):3078-83.
6
On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Transfusion. 2006 Sep;46(9):1652-6. doi: 10.1111/j.1537-2995.2006.00924_1.x.
7
[RCP: prevention in materno-fetal Rh immunization (CNGOF, December 2005). We don't have to forget to control the efficacy of these guidelines, as well as the prescription of the innovating technique in this field].
Gynecol Obstet Fertil. 2006 Apr;34(4):358-9. doi: 10.1016/j.gyobfe.2006.02.006. Epub 2006 Apr 17.
8
[Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
Ugeskr Laeger. 2004 Aug 30;166(36):3073-8.
9
Anti-D guidelines.
Br J Fam Plann. 2000 Oct;26(4):244.
10
Zotero 插件